Azienda Ospedaliera Universitaria Integrata Verona
Clinical trials sponsored by Azienda Ospedaliera Universitaria Integrata Verona, explained in plain language.
-
New procedure may offer safer option for pancreatic tumor patients
Disease control OngoingThis study compares a newer, less invasive procedure called endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) with standard surgery for treating pancreatic insulinoma, a small tumor that causes low blood sugar. About 60 adults with a single tumor 2 cm or smaller will…
Phase: NA • Sponsor: Azienda Ospedaliera Universitaria Integrata Verona • Aim: Disease control
Last updated May 17, 2026 08:21 UTC
-
Heart registry tracks 1,000 patients to predict future attacks
Knowledge-focused OngoingThis study looks back at 1,000 people with suspected heart artery disease who had a special test (FFR) to measure blood flow. Researchers will track their health for up to 10 years to see which blockages lead to heart attacks or other problems. The goal is to learn how to better …
Sponsor: Azienda Ospedaliera Universitaria Integrata Verona • Aim: Knowledge-focused
Last updated May 17, 2026 08:21 UTC
-
New marker may predict pancreatic tumor aggressiveness
Knowledge-focused OngoingThis study is for 100 adults with non-functional pancreatic neuroendocrine tumors (NF-pNETs). Researchers want to see if two markers, called ATRX and DAXX, found in biopsy samples taken during an endoscopic ultrasound, can help predict how aggressive the tumor is. The goal is to …
Sponsor: Azienda Ospedaliera Universitaria Integrata Verona • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC